Harmony Biosciences Holdings (HRMY) Net Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,849.00 |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -958.00 |
| Dec 31, 2025 | -2,400.00 |
| Sep 30, 2025 | -353.00 |
| Jun 30, 2025 | 1,313.00 |
| Mar 31, 2025 | -13.00 |
| Dec 31, 2024 | 2,342.00 |
| Sep 30, 2024 | 78.00 |
| Jun 30, 2024 | -1,885.00 |
| Mar 31, 2024 | 4.00 |
| Dec 31, 2023 | 4,497.00 |
| Sep 30, 2023 | -5,103.00 |
| Jun 30, 2023 | 357.00 |
| Mar 31, 2023 | -43.00 |
| Dec 31, 2022 | -5,408.00 |
| Sep 30, 2022 | 8,695.00 |
| Jun 30, 2022 | 286.00 |
| Mar 31, 2022 | 1,281.00 |
| Dec 31, 2021 | 2,527.00 |
| Sep 30, 2021 | -292.00 |
| Jun 30, 2021 | 4,668.00 |
| Mar 31, 2021 | 25,968.00 |